调味品龙头来袭!海天味业启动港股招股

香港,2025年6月13日 - (亚太商讯 via SeaPRwire.com) - 消费板块因其兼具「高安全边际」与「成长确定性」,历来是价值投资的首选。今年以来,以泡泡玛特、蜜雪冰城、老铺黄金为代表的消费标的受到资金热捧。在港股消费赛道持续升温之际,又一细分领域龙头强势叩门,为港股消费赛道再添一把火。6月11日,中国调味品行业的领军者 - 佛山市海天调味食品股份有限公司(「海天味业」,股份代号:3288.HK)正式启动港股招股,拟全球发售263,237,500股H股,每股发售价介乎35.00港元至36.30港元,募资总额约95.56亿港元,预期于6月19日登陆联交所主板。中金、高盛、摩根士丹利担任联席保荐人。资本抢筹 投票中国消费确定性据了解,从2025年1月13日递表港交所申请赴港上市,到5月23日通过港交所聆讯,海天味业仅用了4个多月的时间,如此紧凑且顺畅的进程,在众多赴港上市企业中较为罕见。「闪电上市」背后,国际资本对中国核心消费资产的渴求已不言而喻。「从路演热度看,这可能是今年最不需要推销的新股。」一位参与路演的投行人士透露。而其豪华的基石投资者阵容,更是这场资本盛宴的有力佐证。根据招股书,本次IPO,海天味业共吸引了高瓴、GIC、加拿大皇家银行、源峰基金等8家国内外顶级投资机构,作为基石投资者合计认购5.95亿美元的发售股份,按发售价中位数35.65港元算,相当于提前锁定49.74%的发行份额(发售量调整权及绿鞋前)。招股首日,国际配售获市场踊跃认购,彰显其对专业投资者的强大吸引力。资本抢筹海天味业,不仅是对中国消费市场韧性与潜力的深刻认知,更是对海天味业作为行业龙头长期价值的的深度押注。公开数据显示,2013年至2023年间,在全球领先调味品企业中,海天味业是全球唯一一家实现收入双位数增长的企业。2024年,海天味业净利润率高达23.6%,显著领先国际同行。三重护城河 铸就「酱茅」底气作为中国调味品龙头,海天味业能够在庞大业务规模的基础上持续保持稳健增长态势,在于其始终秉持长期主义发展战略,深耕产品创新、研发投入与渠道建设三大核心领域,不断夯实自身竞争力,为业绩的可持续增长构筑坚实基础。在产品端,海天味业拥有深入亿万消费者味蕾记忆的国民产品和产品家族,7个年收入超10亿级的大单品系列,31个年收入1亿级以上产品系列,横跨酱油、蚝油、调味酱、食醋、料酒等多个品类,构成一道难以逾越的产品护城河。同时,在产品健康化、产品口味风味升级、个性化定制化功能产品等方面不断创新,持续丰富现有产品系列,捕捉消费升级机遇。这种「存量优化+增量开拓」的策略,使其产品市场竞争力不断提高,推动收入增长。于2024年,海天味业调味酱、其他调味品等产品合计收入同比增长14.0%,贡献25.1%的收入规模。在研发端,海天味业长期坚持科技立企,截至2024年底,过去十年累计研发投入超59亿,并转化为超1,000项专利,涵盖产品研发、菌种培育、酿造关键装备、极致检测技术等。海天味业通过将古法酿造等传统工艺与现代科技智能相融合,实现「酱」心「智」造。2025年1月,海天味业广东高明生产基地,凭借着超5项全球领先的智能酿造技术成果,被世界经济论坛评为「灯塔工厂」,成为全球灯塔网络中首家且唯一酱油生产工厂,标志着海天智能酿造达国际顶级水平,也彰显其以科技驱动产业转型的卓越实力。在渠道端,海天味业以经销为主,积极开拓市场,其销售网络覆盖全国近100%地级市、90%县级市,终端销售网点多达300万个,形成行业内覆盖最广、下沉最深的立体化全国销售网络,可全面触达各类消费群体。根据凯度《2024年品牌足迹报告》,在中国,「海天」以超80%的家庭渗透率,位居中国消费者首选品牌第四、调味品品牌第一。长线投资价值收获市场认可 成长潜力可期得益于扎实的基本面与品牌声誉,海天味业长线投资价值获得资本市场普遍看好。平安证券表示,海天味业作为调味品龙头,在品牌、产品、渠道方面竞争优势突出,市场份额持续提升,看好其长期发展。另有知名券商研报指出,短期来看,近期国家政策对消费定调积极,后续促消费范围与力度有望加大,餐饮消费场景有望稳步恢复,进而对海天味业餐饮端产品需求起到一定提振。中长期来看,随着居民健康意识提升,高品质的健康产品有望成为调味品行业未来发展趋势之一。海天味业积极拓展市场、优化产品结构,并专注产品研发,开发新品类,市场竞争力有望进一步提升。海通国际则认为,海天味业港股上市为国际化战略奠定基础,随着其有序推进海外布局,中长期公司业绩有望受益于消费基础良好、调味品需求旺盛的海外市场。此次赴港上市,标志着海天味业迈出国际化战略的关键一步。港股上市不仅有助于其优化资本结构、提升品牌国际知名度,更为公司拓展海外市场、深化全球供应链、引进国际资源搭建更广阔平台。在全球经济复甦与中国品牌加速出海背景下,海天味业有望抓住消费升级与全球调味品市场扩容的双重红利,实现自身投资价值的持续提升。 Copyright 2025 亚太商讯 via SeaPRwire.com.
More
Tat Hong Equipment Service Co., Ltd. Announces 2024/25 Annual Results ACN Newswire

Tat Hong Equipment Service Co., Ltd. Announces 2024/25 Annual Results

HONG KONG, Jun 13, 2025 - (ACN Newswire via SeaPRwire.com) - Tat Hong Equipment Service Co., Ltd. (“Tat Hong” or the “Company”, together with its subsidiaries, the “Group”) (Stock Code: 2153), the first foreign-owned tower crane service provider established in the PRC, has announced its annual results for the year ended 31 March 2025 (“FY2025” or the “Year”).In FY2025, the Group recorded revenue of approximately RMB 634.6 million (2024: RMB682.3 million). Loss attributable to equity holders of the Company for the year ended 31 March 2025 amounted to RMB 120.5 million (2024: RMB95.6 million). The increase in loss was primarily due to (i) slower economic growth and a downturn in the construction industry led to a decline in revenue; and (ii) the adjustment of deferred tax resulted in increased income tax expenses.As at 31 March 2025, the Group is managing a total of 1,180 tower cranes. The Group’s total tonne metres (TM) in use decreased from 3,178,404 for the year ended 31 March 2024 to 3,137,910 for the year ended 31 March 2025. As at 31 March 2025, the Group had 256 projects in progress with a total outstanding contract value of approximately RMB 721.4 million and 38 projects on hand of total expected contract value at approximately RMB 78.7 million.During the financial year, under the effect of insufficient market demand and the decline in the average monthly service price of tower cranes per TM, the supply and demand mismatch had resulted in high market competition in the entire construction machinery industry. To cope with the sluggish market conditions, the Group has developed tailored strategies and continuously adjusted its business mix, progressively reducing the revenue contribution from the real estate sector.In response to the national initiative to vigorously develop clean energy and aligning with market trends and growth potential, the Group has concentrated on thermal power projects and nuclear power projects. Clean energy projects usually entail lengthy construction cycles and large-scale operations, and the Group has obtained significant advantages by leveraging its extensive industry experience, established construction expertise, and strong technical capabilities.In FY2025, the Group accelerated its overseas market presence, thoroughly implemented its operational strategies through its subsidiaries in the Greater Bay Area and in Indonesia, and gradually expanded its fleet of large and medium-sized tower cranes. Up to now, large-tonnage-meter tower cranes have been predominantly deployed in the projects across Hong Kong and Indonesia. In light of the above, clean energy and overseas projects remain the Group’s key priorities for future development.During the year, the Group had continued the investment in the digitalization of the management platform and the research and development of new tower crane technical solutions. As at 31 March 2025, the Group possess 187 registered patents for utility models and inventions relating to tower cranes. The robust technical capabilities will continue to enable the Group to procure projects, and the enhancement in the research and development capabilities for tower crane technical solutions will reinforce the excellent delivery in services.Mr. Sean Yau, CEO of Tat Hong Equipment Service Co., Ltd., said: " In addition to the downturn in the property market and the construction industry, the geopolitical tensions and the depreciation pressure on the RMB further weakened the economy of the PRC. Tackling these economic challenges and the changing business environment., we have promptly adopted adjustments to our development strategies, including the expansion to the clean energy construction segment and the geographical expansion to the Greater Bay Area and Indonesia, and we believe the positive impact will be reflected in the coming years.Mr. Roland Ng, Chairman of Tat Hong Equipment Service Co., Ltd., said: “In the most trying circumstances, we remain steadfast in our original mission. Guided by our core corporate values ‘Virtue , Safety and Excellence , we will continue to excel in our business endeavors. In the coming financial year, we will continue to further strength our position in the above new segments and locations, and seize new opportunities in the market, so as to concentrate on the research and development of new tower crane technologies to equip ourselves with the most robust technical capabilities to deliver excellent services to our clients. Furthermore, we will also continue to achieve resources sharing, cost reduction and efficiency enhancement. With all the above measures, we believe we can fulfil the Group’s goal to become ‘the best construction equipment service provider’ in the industry.”About Tat Hong Equipment Service Co., Ltd. (Stock Code: 2153)Tat Hong Equipment Service Co., Ltd. is the first foreign-owned tower crane service provider established in the PRC. Since 2007, the Group has established as a tower crane service provider for one-stop tower crane solution services from consultation, technical design, commissioning, construction to after-sales services primarily to Chinese Special-tier and Tier-1 EPC contractors. Guided by its core values, “Virtue, Safety and Excellence”, the Group has successfully established its market position and maintained stable, reputable and loyal customer base in the construction industry in the PRC.Media EnquiriesStrategic Financial Relations LimitedHeidi SoTel:(852) 2864 4826Email: heidi.so@sprg.com.hk Mel LaiTel:(852) 2864 4855Email: mel.lai@sprg.com.hk Copyright 2025 ACN Newswire via SeaPRwire.com.
More
ARE Expands India Leadership, Strengthens Regional Role in Climate, Energy, and Food System Transition ACN Newswire

ARE Expands India Leadership, Strengthens Regional Role in Climate, Energy, and Food System Transition

SINGAPORE / INDIA, June 13, 2025 - (ACN Newswire via SeaPRwire.com) - Asia Research & Engagement (ARE), a leading sustainability-focused consultancy and capital markets engagement firm, has expanded its India team with two senior appointments: Shishir Soti, Director, Global Operations and Partnerships and Arun Kumar, Strategic Advisor – Power Markets and Technology Innovation.Founded in 2013 and headquartered in Singapore, ARE works across Asia’s key economies – including China, India, and Japan – to drive sustainability outcomes through the alignment of capital markets, corporate strategy, and policy. India’s expanding influence in energy, agriculture, and capital markets makes it not just a domestic focus but a regional anchor for accelerating Asia’s net-zero transition.“India is already making bold strides on its decarbonisation journey,” said Benjamin McCarron, Founder & Managing Director, ARE. “Expanding our footprint here strengthens our ability to connect investor expectations and corporate ambition across the region, from Tokyo to Bangkok to Singapore. India’s scale and innovation are pivotal to designing future-fit systems across all of Asia.”Shishir Soti brings more than 25 years of experience to ARE, having held senior positions in banking and financial services at institutions including Standard Chartered and ICICI Bank, as well as senior roles at environmental groups such as the Shakti Sustainable Energy Foundation and Environmental Defense Fund. At ARE he will help deepen the integration of India into ARE’s regional programmes on financed emissions, sustainable food systems, and transition financing. He will also spearhead stakeholder engagement and fundraising strategy for ARE’s India programmes, advancing efforts to align Indian corporates and banks with net-zero goals.“India’s ambition to reach net-zero by 2070 has implications far beyond its borders,” said Soti. “Its energy and agricultural transitions will shape supply chains, investment flows, and climate ambition throughout Asia. I’m proud to support ARE’s work connecting policy, capital, and corporate action at this critical intersection.”Arun Kumar joins ARE with more than 25 years of experience in power markets, technology, and strategy, having held leadership positions at PTC India, HSBC Securities, KPMG and CRISIL where he was consistently ranked among India’s top energy analysts. He will provide strategic insights into regulatory trends, market innovation, and grid decarbonisation.“ARE’s investor-informed approach has already helped shift conversations in China, Japan, and Southeast Asia,” said Kumar. “India’s power market is on the cusp of transformation, and I look forward to helping shape the trajectory through collaborative engagement and technology foresight.”Soti and Kumar will work closely with Rituj Sahu, Director – Protein Transition (India), who has been leading ARE’s work on food systems, climate finance, and impact stewardship in India since 2022. Their collective expertise positions ARE to deepen its regional impact across three core pillars: Energy transition and financed emissions engagement with corporates and banks; Sustainable food and agriculture systems, with a focus on the protein transition; Capital mobilisation, bridging global finance with local sustainability outcomes.The India expansion complements and strengthens ARE’s ongoing work in Singapore, China, Taiwan, Japan, and Thailand – creating a more connected and coordinated platform for sustainable transformation across Asia.“To solve regional sustainability challenges, we need local intelligence, regional coordination, and global capital alignment,” added McCarron. “India is integral to the systems change ARE is driving across the region.”About Asia Research & Engagement (ARE)Creating change through investor-backed engagement. ARE's pioneering approach fills an engagement gap to bring leading investors into dialogue with Asian-listed companies. ARE currently works with investors representing US$10trillion. ARE covers Asian-listed companies from the financial sector, energy-related industries, and food value chains, seeking to advance a sustainable and compassionate Asia.For media interviews and further enquiries, please contactWani DiwakarAsia Research & Engagement (ARE) wani.diwarkar@asiareengage.com Copyright 2025 ACN Newswire via SeaPRwire.com.
More
JBM Healthcare Delivers Strong FY2025 Annual Results, Net Profit Surged 51.2% to HK$197.3 Million ACN Newswire

JBM Healthcare Delivers Strong FY2025 Annual Results, Net Profit Surged 51.2% to HK$197.3 Million

KEY HIGHLIGHTS- Revenue up by 20.7% to HK$782.3 million- Gross profit increased by 22.4% to HK$413.7 million- Consolidated profit attributable to equity shareholders grew by 51.2% to HK$197.3 million- The Board recommends a final dividend of HK11.5 cents per share- Flagship proprietary brands Ho Chai Kung, Po Chai Pills, and Flying Eagle Woodlok Oil delivered robust growth through effective brand management campaigns- Concentrated Chinese medicine granules (“CCMG”) remained resilient, providing a steady contribution to overall business performanceHONG KONG, Jun 12, 2025 - (ACN Newswire via SeaPRwire.com) - JBM (Healthcare) Limited ("JBM Healthcare" or the "Company"; Stock Code: 2161, together with its subsidiaries, the "Group"), a leading branded healthcare products marketer and distributor in Hong Kong, today announced the annual results of the Group for the year ended 31 March 2025 ("FY2025" or the "Reporting Period").Despite a lackluster retail environment in Hong Kong, JBM Healthcare delivered a robust financial and operational performance in FY2025. Revenue from the branded healthcare business rose by 20.7% year-on-year to HK$782.3 million. Gross profit grew by 22.4% to HK$413.7 million, while consolidated profit attributable to equity shareholders surged 51.2% to HK$197.3 million.This significant increase in consolidated profit attributable to equity shareholders was driven by robust sales of flagship brands - including Ho Chai Kung, Po Chai pills, and Flying Eagle Woodlok Oil, complemented by the resilient performance of its CCMG business. These strong results underscore the effective execution of the Group’s integrated sales and marketing strategies, and its strategic foresight in capturing growth opportunities in the branded consumer healthcare market across Hong Kong, Macau, and major cities in the Greater Bay Area.The Board recommends a final dividend of HK11.5 cents per share. Including the interim dividend of HK5.5 cents per share already paid, the total dividend for FY2025 will be HK17.0 cents per share.Solid Performance Across Core SegmentsIn the branded medicines business, sales revenue recorded strong growth of 43.2%, propelled by Ho Chai Kung’s sustained market momentum. Ho Chai Kung successfully expanded its market penetration through precisely targeted marketing initiatives that broadened its consumer base while simultaneously reinforcing brand recognition.Sales in the proprietary Chinese medicines segment grew by 5.0% against the backdrop of softened local retail sentiment of Chinese medicines and herbs, driven by the momentum of flagship brands Po Chai Pills and Flying Eagle Woodlok Oil, alongside the resilient performance of the CCMG business. Po Chai Pills enhanced brand visibility through sustained TVC placements and title sponsorship of popular television programs. Meanwhile, Flying Eagle Woodlok Oil reinforced its market position with an integrated campaign themed “Flying Eagle – The Real Master’s Choice”, highlighted by a viral “Flying Eagle Bro” billboard at Tsim Sha Tsui Star Ferry Pier, which tripled brand awareness.In the health and wellness products segment, revenue increased by 44.9%, driven by the steady growth of Oncotype DX Breast Recurrence Score Test (“Oncotype DX”), along with the expansion of our product portfolio and enhanced marketing efforts to meet consumer healthcare demands of the mass market. Oncotype DX has gained increasing recognition among healthcare professionals in Hong Kong and Macau.Capturing the Growth Potential of Cross-Border E-Commerce and TCM SectorThe Group has made steady progress in expanding its online presence on cross-border e-commerce platforms as well as strategically positioned to capitalise on the growing traditional Chinese medicine (“TCM”) sector in Hong Kong and the Greater Bay Area. The Group’s flagship stores on Tmall Global and JD.com have performed strongly, with Ho Chai Kung ranking among the top 10 overseas medicines during the 2024 Double 11 sales event. To drive sustainable growth, the Group is also diversifying into new categories while enhancing both its B2B and B2C sales networks.Strategic Acquisition of Tin Hee TongIn April 2025, the Group completed the acquisition of a 90% stake in Tin Hee Tong Medicine Factory, Limited, whose flagship product, Tin Hee Tong Tin Hee Pills, is a well-recognised brand in Hong Kong and mainland China, particularly among female consumers for its efficacy in regulating the menstrual cycle and supporting reproductive health. The acquisition expands the Group’s proprietary Chinese medicine portfolio and creates synergies by integrating Tin Hee Tong’s brand with the Group’s manufacturing and marketing strengths. Leveraging its expertise in brand management, the Group will launch a comprehensive marketing campaign to boost awareness, enhance engagement, and broaden distribution.Mr. Patrick Wong, Chief Executive Officer of JBM Healthcare, commented, “Amid the challenging retail environment, we delivered strong financial and operational performance, driven by our robust portfolio, the enduring appeal of our flagship brands, and our unwavering focus on operational excellence.”“Looking ahead, we remain committed to disciplined growth and operational excellence. With rising health awareness, increasingly sedentary lifestyles, and an ageing population continuing to fuel demand, we are well-positioned to capitalise on growth opportunities in the consumer healthcare sector. We will continue to sharpen our brand management capabilities, strengthen our core brand equity, expand our product offerings, and extend our market reach.”About JBM (Healthcare) Limited (Stock Code: 2161)JBM Healthcare is a Hong Kong-based company that markets and distributes branded healthcare products across Greater China, Southeast Asia, and other select countries. The Group is a distinctive player in the sector with marketing expertise and heritage in pharmaceuticals that prioritises product efficacy and quality to meet consumers' healthcare needs. As a renowned healthcare brand operator in Hong Kong, the Group carries a wide-ranging portfolio of branded healthcare products comprising branded medicines, proprietary Chinese medicines, and health and wellness products, which include well-recognised household brands such as Po Chai Pills, Ho Chai Kung Tji Thung San, Tin Hee Tong Tin Hee Pills, Flying Eagle Woodlok Oil), Tong Tai Chung Woodlok Oil, Shiling Oil and Konsodona Medicated Oil. JBM Healthcare has been a constituent stock of the MSCI Hong Kong Micro Cap Index since 27 May 2021. For more details about JBM Healthcare, please visit: www.jbmhealthcare.com.hk Copyright 2025 ACN Newswire via SeaPRwire.com.
More

NEFECON(R) and EVER001 Drive Synergistic Progress as Everest Medicines Advances

HONG KONG, Jun 12, 2025 - (ACN Newswire via SeaPRwire.com) - At the 62nd Congress of the European Renal Association (ERA 2025), Everest Medicines presented new results findings on both NEFECON® (budesonide delayed release capsules), the world’s first and only approved therapy that directly targets the underlying cause of IgA nephropathy (IgAN), and EVER001, a next-generation covalent reversible BTK inhibitor. The latest results provide robust evidence for NEFECON®’s efficacy across the full disease spectrum and reinforce its foundational role in the emerging IgAN treatment strategy: “Treat the Cause, Treat Early, Treat All”. The nine studies covered biomarker-based prediction, treatment outcomes across various diagnostic timelines and baseline kidney function levels, long-term treatment durability, and mechanistic insights.Two studies further validated the critical role of NEFECON® in targeting the underlying mechanisms of IgA nephropathy (IgAN), reinforcing its position as the first-line etiological treatment for the disease. One study, based on the "Four-Hit" hypothesis, demonstrated that NEFECON® significantly impacts the first three pathogenic steps, ultimately reducing the risk of kidney function deterioration by 50%. Another study found that reductions in pathogenic Gd-IgA1 and polymeric IgA levels during the first two months of treatment closely correlated with improvements in proteinuria, suggesting their potential as predictive biomarkers to guide treatment.Two additional studies confirmed the clinical benefits of “Treat Early” with NEFECON®. A subanalysis of the NefIgArd study showed that patients who began treatment within six months of diagnosis experienced greater kidney protection and more significant reductions in proteinuria compared to those diagnosed earlier. This highlights the importance of early intervention to slow disease progression and achieve better long-term outcomes. Another prospective study supported this finding, showing that earlier treatment may more effectively reduce pathogenic immune factors and control inflammation, potentially preventing disease relapse or irreversible progression.Finally, two studies provided strong clinical evidence supporting NEFECON®’s “Treat All” strategy by confirming its broad applicability across different patient types. A subanalysis of the NefIgArd study found that NEFECON® effectively reduced proteinuria and preserved kidney function across all baseline eGFR levels. A separate multicenter study showed that patients with active pathological changes, such as endocapillary hypercellularity or crescent formation, experienced even more pronounced improvements in proteinuria and delayed disease progression.NEFECON® is the first and only fully approved etiological treatment for IgAN in China, the U.S., and Europe. It has been included in the KDIGO 2024 Clinical Practice Guideline For The Management Of Immunoglobulin A Nephropathy (IgAN) And Immunoglobulin A Vasculitis (IgAV) (public review draft). With updated data presented at ERA 2025, NEFECON® further solidified its position as a first-line cornerstone therapy, demonstrating a clear mechanism of action, sustained long-term benefits, and suitability for a wide range of patients. As NEFECON® continues to gain approvals across global markets, expand reimbursement coverage in China, and advance in tandem with diagnostic tools such as the Gd-IgA1 diagnostic kit under development, Everest Medicines is building a comprehensive “diagnosis-treatment-monitoring” ecosystem. This integrated approach is designed to shift IgAN management from symptomatic support toward precise, long-term disease control.In parallel, Everest Medicines’ proprietary next-generation covalent reversible Bruton's tyrosine kinase (BTK) inhibitor, EVER001, was featured in a focused oral presentation at the 62nd Congress of the European Renal Association (ERA 2025). EVER001 has best-in-class potential for the treatment of primary membranous nephropathy (pMN) and other autoimmune kidney diseases such as IgAN, MCD, FSGS, and LN, targeting a global patient population of over 10 million. As no drug is currently approved for pMN, EVER001 offers a promising new option. Preliminary results from the ongoing Phase 1b/2a trial show that EVER001 is well tolerated and demonstrates strong clinical and immunological responses, including reductions in proteinuria and anti-PLA2R autoantibodies. The study also includes long-term follow-up data, supporting its potential in chronic disease management. Everest Medicines is continuing to expand clinical research to gather more data across patient groups and longer treatment durations.This advancement complements NEFECON® and exemplifies Everest Medicines’ “dual-engine” strategy, which combines in-licensed and internally developed innovations to broaden its kidney disease pipeline. Together, NEFECON® and EVER001 empower Everest Medicines to build a precise and durable kidney disease management ecosystem, accelerating global expansion and providing patients with accessible, effective treatment options. Copyright 2025 ACN Newswire via SeaPRwire.com.
More
健倍苗苗二零二五财年全年业绩表现亮眼 纯利飙升51.2%至1.97亿港元 ACN Newswire

健倍苗苗二零二五财年全年业绩表现亮眼 纯利飙升51.2%至1.97亿港元

业绩亮点- 收益增长20.7%至7.8亿港元- 毛利上升22.4%至4.1亿港元- 权益持有人应占综合溢利增长51.2%至1.97亿港元- 董事会建议派发末期股息每股11.5港仙- 凭借有效的品牌管理,旗舰品牌何济公、保济丸和飞鹰活络油实现强劲增长- 浓缩中药颗粒业务表现强韧,为整体业务表现提供稳定贡献香港,2025年6月12日 - (亚太商讯 via SeaPRwire.com) - 健倍苗苗(保健)有限公司(「健倍苗苗」或「公司」;股份代号:2161,连同其附属公司统称「集团」)为香港品牌保健品的领先营销商及分销商,集团今天公布截至二零二五年三月三十一日止年度(「二零二五财年」或「报告期」)的全年业绩。尽管香港零售环境疲软,健倍苗苗于二零二五财年的财务与营运表现仍然出色。集团品牌医疗保健业务的收益按年增长20.7%至7.8亿港元。毛利增长22.4%至4.1亿港元,权益持有人应占综合溢利飙升51.2%至1.97亿港元。权益持有人应占综合溢利大幅增长主要来自旗舰品牌的强劲销售表现,当中包括何济公、保济丸与飞鹰活络油,以及浓缩中药颗粒业务的稳健表现。这一优异表现,显示本集团成功落实整合的线上与线下营销策略,并体现集团的前瞻性市场触角,有效地把握香港、澳门及大湾区主要城市品牌消费健康市场增长机遇。董事会建议派发末期股息每股11.5港仙。包括已派付的中期股息每股5.5港仙,二零二五财年的股息总额为每股17.0港仙。各个核心业务表现卓越在何济公持续销售势头的带动下,品牌药分部的收益录得43.2%的强劲增长。何济公透过精准的市场营销计划扩大市场渗透率,成功扩大消费群体,同时进一步巩固品牌的知名度。在本港中成药及中药材的零售销售放缓的背景下,集团的品牌中药分部仍实现5.0%的增长。此增长主要来自旗舰品牌保济丸及飞鹰活络油的强劲表现,以及浓缩中药颗粒业务的稳健支持。保济丸通过持续的电视广告投放和冠名赞助电视人气节目,进一步提高品牌知名度。与此同时,飞鹰活络油透过以「飞鹰至系真王道」为主题的宣传计划强化市场地位,使其品牌知名度提升三倍,当中位于尖沙咀天星码头的「飞鹰哥」广告板更成功引起热议,迅速在网上疯传。健康保健品分部的销售收益增长44.9%,动力来自安可待乳癌肿瘤基因检测 (「Oncotype DX」)的稳健表现,加上产品组合扩展及加强推广,有效回应大众对健康产品日益增长的需求。Oncotype DX日益受到香港及澳门的医疗机构及医护专业人士的认可。把握跨境电子商务及中医药市场的增长潜力集团在拓展线上业务方面取得稳步进展,尤其是跨境电子商务平台,同时策略性地进行部署,把握香港及大湾区持续增长的传统中药行业机遇。集团在天猫国际和京东的旗舰店表现强劲,何济公于2024年双11期间位列十大海外药品畅销榜。为了推动可持续增长,集团正丰富多元化产品组合,同时加强B2B和B2C的销售网络。策略性收购天喜堂二零二五年四月,集团完成收购天喜堂药厂有限公司90%的股权,其旗舰产品「天喜堂天喜丸」于香港及中国内地享有极高的品牌知名度,特别受到女性消费者青睐,因其在调节女性生理周期及促进生殖健康方面具显著功效。这项收购进一步丰富了集团的品牌中药产品组合,并透过整合天喜堂品牌与集团现有的生产与营销能力,创造显著的协同效应。集团将凭借在品牌推广方面的丰富经验,开展全方位的市场推广计划,以提升该品牌知名度,加强与消费者的互动,以及扩展分销网络,进一步拓展客户基础。健倍苗苗行政总裁黄一伟先生表示:「面对零售环境的种种挑战,我们依然交出亮丽的财务及营运成绩,这有赖于我们多元而稳健的产品组合、旗舰品牌持久的市场吸引力,以及我们对卓越营运的不懈追求。展望未来,我们将继续秉持稳健增长与卓越营运的原则。随着健康意识提升、久坐的生活模式普及以及人口老龄化持续带动需求,我们已做好充分准备把握消费保健行业的增长机遇。我们将持续强化品牌管理能力,巩固核心品牌价值,扩展产品组合,并扩大市场覆盖范围。」有关健倍苗苗(保健)有限公司 (股份代号:2161)健倍苗苗是设于香港的品牌医疗保健品推广及分销公司,产品据点遍及大中华、东南亚及其他选定国家。集团拥有丰富的行销专业知识并具备深厚的制药背景,秉承产品功效和品质至上的优良传统,在行业内定位独特,致力于满足消费者的保健需要。作为本地领先的品牌医疗保健品运营商,集团拥有一广泛系列品牌医疗保健品,包括品牌药、品牌中药及健康保健品,其中包括「保济丸」、「何济公止痛退热散」、「天喜堂天喜丸」、「飞鹰活络油」、「唐太宗活络油」、「十灵油」、「镇痛霸祛风活络油」等家喻户晓的传统品牌。而自2021年 5月27日,集团获纳入 MSCI 香港微型股指数成份股。有关集团详情,请浏览:www.jbmhealthcare.com.hk Copyright 2025 亚太商讯 via SeaPRwire.com.
More

质量基石的守护者:检测检验行业赋能高质量发展

香港,2025年6月12日 - (亚太商讯 via SeaPRwire.com) - 改革开放以来,中国经济实现了高速增长。然而,随着经济的发展,如何保持长期的生产率增长成为关键问题。2017年,中国共产党第十九次全国代表大会首次提出"高质量发展",标志着中国经济由高速增长阶段转向高质量发展阶段。2023年2月,国务院印发《质量强国建设纲要》,强调国家质量基础设施是实现高质量发展的重要保障。检验检测行业作为高技术服务业,在推动国民经济高质量发展方面发挥着重要作用。据行业调查报告,中国独立检测检验行业市场总规模预计将从2022年的4,276亿元增长至2027年的7,081亿元,复合年增长率为10.6%。其中,建设工程检测检验行业是最大的子板块,预计到2027年市场规模将达到约1,500亿元。广东省作为检测检验行业的第一大省,通过"百千万工程"加速基础设施建设,促进了对建设工程检测的需求。粤西地区作为三线及以下县市的检测需求集中地,市场规模预计将从2023年的36亿元增长至2028年的65亿元,复合年增长率为12.7%。在粤西地区,广东集信国控检测认证技术服务中心股份有限公司(简称"集信国控")表现突出,前身为信宜市建设工程质量检测站,成立于2000年,2024年在香港联合交易所GEM板上市。截至2024年12月,公司已获得建设工程、环境、产品质量、食品、农林水畜渔等五个检测领域41个检测类别、3183+个检测参数,在全省县市级同类公司中名列前茅。受疫情影响,集信国控2022年的营业收入下降到1996万人民币,但公司凭借清晰的战略规划和专业的检测能力,业务迅速恢复增长。2024年,公司营业收入达到5526万人民币,较2023年增长33.2%,毛利润增长17.9%,净利润增长23.0%。建设工程检测检验板块是公司最大的业务板块,占比超过50%。公司现金流充足,2024年现金及现金等价物为99.86百万元人民币,并宣派了每股0.16港元的末期股息。集信国控正积极向综合性检测服务机构迈进,布局交通检测、水利检测、消防检测等新板块。2025年4月,收购了茂名市粤水工程检测有限公司51%的股权,开拓水利检测业务。此外,公司还与佛山市高明区当地国企合资成立子公司,拓展区域市场。借助香港上市平台,集信国控有望实现跨越式发展。在国家高质量发展和乡村振兴政策的双重推动下,检测检验行业将迎来高速发展。集信国控凭借国企公信力、技术实力和战略布局,为高新技术产业链供应链发展保驾护航,提升行业服务水平和国际竞争力。 Copyright 2025 亚太商讯 via SeaPRwire.com.
More

耐赋康(R)与EVER001协同发力 云顶新耀推动肾病治疗进入精准管理新阶段

香港,2025年6月12日 - (亚太商讯 via SeaPRwire.com) - 在第62届欧洲肾脏协会(ERA 2025)大会上,云顶新耀(HKEX: 1952.HK)旗下全球首个对因治疗IgA肾病药物耐赋康®(布地奈德肠溶胶囊,NEFECON®)和新一代共价可逆BTK抑制剂EVER001都发布了最新研究成果。其中,耐赋康®发布9项最新研究成果,涵盖生物标志物预测、不同诊断时间和肾功能基线人群的疗效评估、长期治疗效果的持续性分析及作用机制验证,全面印证其在"对因治疗、尽早治疗、全部治疗"新管理策略下的广泛适用性与长期临床价值。两项研究深入验证了耐赋康®在干预IgA肾病致病机制中的关键作用,从机制层面明确支持耐赋康®作为IgAN首选"对因治疗"方案的定位。其中一项研究基于"四重打击"理论发现,耐赋康®可同时显著作用于第一、第二、第三重打击,最终实现肾功能恶化风险减少50%;另一项研究则显示,治疗早期(前两个月)血液中致病性Gd-IgA1、多聚IgA水平的下降幅度与蛋白尿改善紧密相关,有望作为预测疗效、指导治疗的潜在生物标志物。另外两项研究成果证实,耐赋康®在"尽早治疗"IgA肾病方面可实现具有更显著临床获益。其中一项NefIgArd研究子分析显示,确诊时间不足6个月的IgA肾病患者在接受耐赋康®治疗后,肾功能保护效果显著好于确诊时间更久的患者,蛋白尿改善幅度也更大。这意味着越早使用耐赋康®,越能延缓肾功能损伤,长期获益也更大。另一项前瞻性研究也指出,早期治疗不仅有助于减少致病性免疫因子的产生,还可能更有效控制炎症过程,避免病情反复或进入不可逆阶段。还有两项研究为耐赋康®"全部治疗"策略提供了坚实的临床依据,进一步确认耐赋康®对不同类型IgA肾病患者的广泛适用性。一项NefIgArd研究子分析发现,不论患者起始时的肾功能水平高低,耐赋康®均能有效减少蛋白尿,并在各时间点维持肾功能稳定;另一项多中心研究表明,对于存在活动性病理改变(如毛细血管增生、新月体形成)的患者,耐赋康®同样展现出更显著的蛋白尿改善,并有效延缓疾病进展。作为全球唯一在中国、美国和欧洲获得完全批准的IgA肾病对因治疗药物,耐赋康®不仅已被中外权威指南《2024版KDIGO IgA肾病和IgA血管炎临床管理实践指南(公开审查版)》,以及《中国成人IgA肾病及IgA血管炎临床实践指南(预审版本)》推荐,更通过本次ERA 2025大会的数据更新,再次巩固了其机制优势、适用人群广度与长期疗效可持续性。随着全球多个国家批准上市、国内医保覆盖落地,以及与生物标志物诊断工具(Gd-IgA1诊断试剂盒)的联动开发推进,耐赋康®正在构建"诊断+治疗+监测"一体化解决方案,引领IgA肾病从对症支持转向精准对因治疗的长期管理转变。与此同时,云顶新耀另一款核心管线,自主研发、拥有全球权益的新一代共价可逆BTK抑制剂EVER001也在本届ERA大会上首次以集中口头报告形式发布其在原发性膜性肾病(pMN)中的阶段性临床研究数据,作为一款潜在"同类最佳"药物,适用于原发性膜性肾病(pMN)、IgA肾病、微小病变病、FSGS和狼疮性肾炎等多种自身免疫性肾脏疾病,覆盖超1000万患者潜在人群。该产品目前正在开展1b/2a期临床研究,并已收集到更多患者的长期随访数据。初步结果显示,EVER001在原发性膜性肾病中展现出良好的安全性、耐受性以及显著的临床缓解和免疫学缓解效果,进一步验证了其作为治疗蛋白尿型自身免疫性肾病新方案的潜力,未来将与耐赋康®形成机制和应用上的互补,拓展公司在肾病领域的产品布局。耐赋康®与EVER001分别代表云顶新耀在"授权引进"和"自主研发"方面的成果,体现"双轮驱动"战略在肾病这一蓝海赛道的落地成效。两款产品的协同推进,将助力公司构建更精准、长期的肾病管理体系,并加快全球拓展,为更多患者提供可及、可靠的治疗选择。 Copyright 2025 亚太商讯 via SeaPRwire.com.
More
10 winners selected at 8th edition of Start-up Express ACN Newswire

10 winners selected at 8th edition of Start-up Express

- On the Final Pitching Day of Start-up Express, 10 winners were selected, with xxx and AniTech Limited receiving the ESG Award and the My Favourite Start-up Award respectively- More than 200 industry players attended, helping start-ups to establish connections and increase exposure, and continue to promote Hong Kong's entrepreneurial ecosystem- Majority of the 10 winners are health tech start-ups, while others represented sectors such as green tech, smart city and AI SolutionsHONG KONG, Jun 12, 2025 - (ACN Newswire via SeaPRwire.com) - 10 start-ups were selected as winners at the eighth edition of Start-up Express, an entrepreneurship development programme organised by the Hong Kong Trade Development Council (HKTDC) which came to a successful conclusion. The ESG Award was presented to Green Vigor Limited in recognition of the best sustainable and socially impactful business solution, and AniTech Limited won the My Favourite Start-up Award as determined through audience live polling. The 10 start-ups will participate in a series of local and overseas business events organised by HKTDC to develop their profiles through building connections, exploring markets, seeking partners and enhancing brand awareness.HKTDC is fully committed to supporting and promoting the development of start-ups, helping them to expand into Mainland and international markets to showcase Hong Kong’s strengths in innovation and technology.Iris Wong, Director of Merchandise Trade and Innovation & External Relations of HKTDC said: “Start-up Express serves as the launchpad for Hong Kong’s brightest tech innovators. As HKTDC’s flagship start-up development programme, our mission is to help local tech start-ups build capability and connections, explore new markets, seek business and funding partners, and enhance their brand awareness. I am proud to share that we have already assisted 70 Hong Kong start-ups to scale-up in Hong Kong and expand into overseas markets since we first held Start-up Express in 2018. Many of these start-ups have achieved remarkable success, earning global awards, securing significant investments, and forming key business partnerships. This demonstrates how the HKTDC platform helps bring Hong Kong start-ups into the limelight and accelerate their success.”This year’s Start-up Express attracted more than 200 applications. The majority of the 10 winners are health tech start-ups while the rest represent green tech, smart city and AI solutions. Booths were also set up during the event enabling the Start-up Express finalists to showcase their businesses to all attendees and participants.Comprehensive range of networking and matching initiatives provided to winning start-upsThe 10 winners were chosen from 20 contestants during the final pitching round with each presenting their innovative business ideas and answering questions raised by the distinguished judging panel. The 10 winning start-ups are: ACTuWISE Limited, Decennium Platforms Limited, AniTech Limited, Digitoe Limited, CELLmeric Limited, RT Healthtech Co. Limited, Firefilm Group Limited, Albacastor Technology Limited, Entoptica Limited and Green Vigor Limited.Click here to download the list of winners and their company profiles.The HKTDC will arrange a series of exposure opportunities for the winning teams to interact with potential investors, buyers and partners.Judges praised the winners for their performance and awareness of market trendsOne of the judges, Herbert Chia, Senior Advisor of Alibaba Cloud (North APAC Region), said: “We are always surprised by the new start-ups in each year's awards. In the face of rapid AI development, many local start-ups have quickly incorporated AI into their business operations, showing that they are innovative, capable and also closely following the market trend.”Another judge, Jimmy Tao, Chairman of Hong Kong Startup Council, said: “The quality of this year's competition is high, with products and services covering different technologies, especially artificial intelligence, green tech and medical innovation. We are pleased to see the new generation of start-ups continue to break new grounds in innovation and technology, demonstrating their unlimited potential and creativity, thereby contributing to society’s advancement. Hong Kong's start-up scene continues to grow vigorously, with a record number of 4,694 start-ups last year, demonstrating Hong Kong's promising outlook and increasing attractiveness to do business and as an ideal to set up a start-up. We believe that this year's winning start-ups will gain valuable opportunities to expand their markets and build networks through Start-up Express.”Start-up Express helps start-ups secure investment and partnership opportunitiesStart-up Express provides extensive promotional opportunities for start-ups with winners able to take part in exhibitions in Mainland China and internationally, attend meetings with investors to learn more about the industry, market trends and investors’ preference.Libpet Tech, a Start-up Express winner in 2024, has recently completed a US$3 million seed funding, and the investment will be utilized for technology upgrades and international market expansion. Jojo Xu, CEO of Libpet Tech, said: "Participating in Start-up Express has given us more exposure and enhanced our brand awareness, as seen from the increased attention from potential customers and investors. We are grateful for the investors' confidence in our company. We will join hands with our public and private partners to integrate robotics into daily life and promote human-centric smart mobility.”The 4th Start-up Express International returns in December with global start-upsThe HKTDC has always given its full support to Hong Kong’s entrepreneurial ecosystem, helping to maintain the city’s status as a competitive business centre and hub for innovation. Start-up Express International was launched in 2022 for overseas early-stage start-ups to share the stage with local Start-up Express winners. The past three editions have attracted participants from around the world, including Australia, France, Germany, Japan, Korea, Turkey, Singapore, United Arab Emirates and the United States. The 4th Start-up Express International will return during Entrepreneur Day in December and the HKTDC will support the winners in setting up their businesses in Hong Kong and to explore the mainland and Greater Bay Area markets.Start-up Express: https://portal.hktdc.com/start-upexpress/Photo download: http://bit.ly/4jPwedcRepresentatives of the 10 winners of Start-up Express took a group photo with the judges and guests. Back row, from left to right: Herbert Chia, Senior Advisor of Alibaba Cloud (North APAC Region), Alan Cheung, Chairman & Managing Director of Grandion Group, Anthony Chan, CEO of Isola Capital, Iris Wong, HKTDC’s Director of Merchandise Trade and Innovation & External Relations, Matthias Knobloch, Managing Partner & CEO of Betatron Venture Group, Lui Tong, Chairman of PRD Angels and Jimmy Tao, Chairman of Hong Kong start-up CouncilStudents from local schools were invited to the Final Pitching Day of Start-up Express to present their innovative solutions. They were mentored by Sarah Tong, co-founder of Big Bang Academy, winner of Start-up Express 2023, who also presented the awardsMore than 200 industry players attended the Final Pitching Day of Start-up Express, giving the opportunity for start-ups to network with investors and business leadersBooths were also set up during the event, where finalists showcased their businesses to all attendees and participantsHKTDC Media Room: http://mediaroom.hktdc.com/enMedia enquiriesPlease contact the HKTDC’s Communications & Public Affairs Department:Stanley So Tel: (852) 2584 4049 Email: stanley.hp.so@hktdc.orgKaty Wong Tel: (852) 2584 4524 Email: katy.ky.wong@hktdc.orgSerena Cheung Tel: (852) 2584 4272 Email: serena.hm.cheung@hktdc.orgClayton Lauw Tel: (852) 2584 4472 Email: clayton.y.lauw@hktdc.orgAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit:www.hktdc.com/aboutus. Copyright 2025 ACN Newswire via SeaPRwire.com.
More
This Technology is Conquering the World: Neutrinovoltaics Redefining Global Infrastructure ACN Newswire

This Technology is Conquering the World: Neutrinovoltaics Redefining Global Infrastructure

MUNICH, June 11, 2025 - (ACN Newswire via SeaPRwire.com) - A global energy transition is no longer optional-it's a necessity. But behind the scenes of solar and wind, another technology is entering industrial reality with far greater implications. Neutrinovoltaic technology, developed by the Neutrino® Energy Group, is not a distant concept. It's an operational platform for decentralized, 24/7 energy generation that is now expanding into mobility, aerospace, marine systems, and even high-security communications.Neutrinovoltaic Energy: Quiet, Infinite, Everywhere. Neutrinovoltaic technology converts the kinetic energy of neutrinos and other non-visible radiation into electricity. These omnipresent particles trigger atomic vibrations in a nanomaterial composed of alternating layers of graphene and doped silicon. The resulting resonant frequency is transformed into direct current. Far from ambient energy scavenging, this is a controlled, scalable generation method already powering advanced applications.Power Without Fuel: The Neutrino Power CubeThe Neutrino Power Cube is a compact, modular, and emission-free energy system delivering 5 to 6 kilowatts of continuous power. Weighing just 50 kilograms, it operates silently and autonomously, independent of weather or location. With no fuel, no combustion, and no grid connection required, the Cube holds the potential to decentralize energy infrastructure and become a cornerstone of clean, off-grid power generation worldwide.Autonomous Mobility: The Pi CarThe Pi Car applies neutrinovoltaic integration to electric vehicles. Instead of relying on traditional charging infrastructure, the Pi Car generates power continuously by embedding neutrinovoltaic materials into structural components like the body panels and roof. After an hour in ambient conditions, the vehicle can achieve up to 100 kilometers of additional range. Collaborators include Simplior Technologies for AI-based energy optimization, C-MET Pune for materials development, and SPEL Technologies for battery integration. The concept also supports retrofitting existing EV platforms to enhance range and energy independence.Flight Beyond Limits: Pi FlyPi Fly is Neutrino® Energy Group's aeronautics program, developing UAVs powered by onboard neutrinovoltaic systems and supercapacitor storage. Current prototypes include multirotor and flying wing models. The next phase targets autonomous VTOL aircraft for cargo delivery. Supporting this effort are mobile hydrogen refueling units, also powered by neutrinovoltaics, enabling off-grid aviation infrastructure.Maritime Transformation: Nautic PiNautic Pi brings this energy platform to the sea. Neutrinovoltaic-powered marine vessels are under conceptual development, allowing autonomous navigation without onboard fuel or external charging. The system is particularly suited for long-duration missions, remote operations, and submersible platforms.Communication Breakthrough: Project 12742Finally, Project 12742 explores neutrino-based data transmission. Unlike radio signals, neutrinos pass through dense materials with minimal interference. This allows for real-time, secure global communication even through rock, oceans, or planetary bodies-an enormous leap for high-security and interplanetary data systems.As governments and industries seek viable decarbonization paths, the Neutrino® Energy Group is no longer just proposing solutions-it's deploying them. With a multidisciplinary team of hundreds of researchers, engineers, and scientists from over 40 countries, strategic alliances, and a growing portfolio of high-impact applications, neutrinovoltaic technology isn't coming-it's already here. And it's conquering the world.Neutrino Energy GroupNeutrino Scientific BoardHolger Thorsten Schubart - CEOWebsite: www.neutrino-energy.comContact InformationHolger Thorsten SchubartCEO and member of the Scientific Advisory Boardoffice@neutrino-energy.com+493020924013Related Videohttps://www.youtube.com/watch?v=LiswrRR8H2QSOURCE: Neutrino Energy Group Copyright 2025 ACN Newswire via SeaPRwire.com.
More
HKTDC Design Gallery x STICKYLINE present: “Love HK” Exhibition ACN Newswire

HKTDC Design Gallery x STICKYLINE present: “Love HK” Exhibition

HONG KONG, Jun 11, 2025 - (ACN Newswire via SeaPRwire.com) - The Hong Kong Trade Development Council (HKTDC) Design Gallery continues to champion original Hong Kong designs. The annual “Love HK” exhibition returns from 11 June to 6 July, in partnership with STICKYLINE, a prominent creative team in Hong Kong, and will debut their latest artwork, “The Carved Duo”, at the Design Gallery Wan Chai shop, featuring large-scale artistic paper sculptures that capture the essence of a traditional dragon and phoenix grand hall.Carved dragon and phoenix statues were iconic decorations in Hong Kong’s banquet halls during the 1970s. STICKYLINE reimagines these symbols through contemporary geometric paper sculptures, incorporating pixel-like grid patterns into the Design Gallery’s window. This artwork retains the auspicious meanings of the dragon and phoenix while refining their forms, exploring how cultural heritage can evolve within modern contexts.STICKYLINE’s co-founder Mic Leong said, “We are thrilled to collaborate with the HKTDC Design Gallery on the ‘Love HK’ exhibition. In line with the theme, we have created paper sculptures inspired by the traditional dragon and phoenix grand halls found in old restaurants which were used to symbolise the city’s economic boom and opulence. Although modern restaurants have phased out such designs, these motifs are resurfacing in unexpected ways, such as tattoo art, wedding backdrops, and avant-garde photography, reflecting younger generations’ reinterpretation of tradition. Through this piece, we aim to revive the collective memories of old-school restaurants and showcase Hong Kong's unique charm.”In addition to the dragon and phoenix installation, the main entrance of the Design Gallery features a playful paper sculpture of the word “HEY”. Soilworm Lai, Co-Founder, STICKYLINE, explained, “‘HEY’ is a phonetic nod to the word ' (double happiness)’. We aspire to merge modern elements with the traditional dragon and phoenix theme, offering a friendly greeting to visitors.”Curated selection of Hong Kong-themed productsDuring the exhibition, the Design Gallery will feature a curated selection of Hong Kong-themed products, including AMAZING STUDIO Neon Light Hong Kong Metal Badge Pin, CAMEL Modern Hong Kong Culture Glass Vacuum Flask, IRON WORKSHOP Hong Kong Silk Scarf Map, and PLAYFUL SOCKS Dragon Phoenix Happiness Socks.Share on social media for shopping discountVisitors can enjoy an additional 10% discount on purchases during the exhibition by taking photos of the exhibits and sharing these on social media, tagging @HKTDC Design Gallery.Design Gallery Love HK x STICKYLINE – “The Carved Duo” ExhibitionDate11 June – 6 July 2025VenueHKTDC Design GalleryG/F, Hong Kong Convention & Exhibition Centre, 1 Harbour Road, Wan Chai, Hong KongOpening hoursMonday – Sunday & Public Holidays: 10:30am – 7:30pmEnquiries2584 4146 / 2584 4149Websitehttps://hkdesigngallery.hktdc.com/Social MediaFacebook: www.facebook.com/HKTDC.DesignGalleryInstagram: www.instagram.com/hktdc_designgalleryPhoto download: https://bit.ly/4dXb9fzThe HKTDC Design Gallery annual “Love HK” exhibition returns from 11 June to 6 July, in partnership with STICKYLINE, a prominent creative team in Hong Kong, to debut their latest artwork, “The Carved Duo”, at the Design Gallery Wan Chai shop, featuring large-scale artistic paper sculptures that capture the essence of traditional dragon and phoenix grand hallSTICKYLINE, founded in Hong Kong by creative designers Mic Leong (left) and Soilworm Lai (right), creates unique, large-scale polyhedral sculptures that showcase the complexity of creative engineering, mathematics and geometric structuresCurated selection of Hong Kong-themed productsAMAZING STUDIONeon Light Hong Kong Metal Badge PinPrice: HK$78CAMELModern Hong Kong Culture Glass Vacuum FlaskPrice: HK$439IRON WORKSHOPHong Kong Silk Scarf MapPrice: HK$370KONSEPTRemote Control Block Hong Kong TramPrice: HK$799PLAYFUL SOCKSDragon Phoenix Happiness SocksPrice: HK$99YI-MINGPOLA Hong Kong Print Chinese Folding FanPrice: HK$168WebsiteHKTDC Media Room: https://mediaroom.hktdc.com/enMedia enquiriesPlease contact the HKTDC’s Communications & Public Affairs Department:Serena CheungAgnes WatTel: (852) 2584 4272Tel: (852) 2584 4554Email: serena.hm.cheung@hktdc.orgEmail: agnes.ky.wat@hktdc.orgAbout STICKYLINESTICKYLINE, founded in Hong Kong in 2011 by creative designers Mic Leong and Soilworm Lai, creates unique, large-scale polyhedral sculptures that showcase the complexity of creative engineering, mathematics and geometric structures. They transform two-dimensional planes into three-dimensional forms through a process of deconstruction and reconstruction. They have collaborated with international brands including Hermès, Ralph Lauren, and Mercedes-Benz.Discover more at: https://www.stickyline.hkAbout HKTDC Design GalleryEstablished in 1991, the Hong Kong Trade Development Council’s Design Gallery (DG) promotes Hong Kong’s creativity innovation in design. With two physical outlets in Hong Kong and Taobao and JD International online stores, DG helps Hong Kong brands connect and collaborate with buyers to grow and expand in Mainland China and beyond. The DG online shop also provides suppliers with local online sales channels. DG’s entry into the ASEAN market enables Hong Kong brands to connect with overseas consumers and buyers.Discover more at: https://hkdesigngallery.hktdc.com/About HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. Copyright 2025 ACN Newswire via SeaPRwire.com.
More
这项技术正在征服世界:中微子光伏技术正在重新定义全球基础设施 ACN Newswire

这项技术正在征服世界:中微子光伏技术正在重新定义全球基础设施

尼黑, 2025年6月11日 - (亚太商讯 via SeaPRwire.com) - 全球能源转型已不再是可选项,而是势在必行。然而,在太阳能和风能的背后,一项具有更深远意义的技术正逐步走入工业现实。由 Neutrino® 能源集团开发的中微子光伏技术,不再是遥不可及的概念,而是已投入运行的分布式全天候能源生成平台,并正扩展至交通、航空航天、海洋系统,甚至高安全通信领域。中微子光伏技术 通过将中微子及其他不可见辐射的动能转化为电能实现发电。这些无处不在的粒子会激发一种由石墨烯与掺杂硅交替层构成的纳米材料中的原子振动,产生共振频率并被转换为直流电。这种方式远非环境能量“采集”,而是一种可控、可扩展的发电方法,已被用于多项先进应用。无需燃料的电力:中微子能量方块中微子能量方块是一种紧凑型、模块化、无排放的能源系统,可持续输出5至6千瓦电力。设备仅重50公斤,运行时安静、无需人工干预,且不受天气与地理位置影响。它不依赖燃料、不发生燃烧、无需接入电网,具备去中心化能源基础设施的潜力,有望成为全球清洁、离网发电的重要支柱。自主移动出行:Pi CarPi Car 将中微子光伏技术应用于电动汽车领域。它不依赖传统充电基础设施,而是通过将中微子光伏材料嵌入车身面板、车顶等结构部件中,实现持续发电。在常规环境条件下,仅需一小时即可为车辆带来最多达100公里的额外续航里程。合作伙伴包括负责基于人工智能的能源优化的 Simplior Technologies、从事材料研发的 C-MET Pune,以及提供电池集成方案的 SPEL Technologies。该技术理念还支持对现有电动车平台进行改造,从而提升续航能力并实现能源独立。突破飞行极限:Pi FlyPi Fly是 Neutrino® 能源集团的航空项目,致力于开发由机载中微子光伏系统和超级电容存储供能的无人飞行器(UAV)。目前的原型机包括多旋翼和飞翼机型。下一阶段的目标是开发用于货物运输的自主垂直起降(VTOL)飞行器。为支持该项目,还配备了由中微子光伏技术供能的移动氢燃料补给装置,推动离网航空基础设施的发展。海洋革新:Nautic PiNautic Pi 将这一能源平台拓展至海洋领域。采用中微子光伏技术驱动的船舶目前正处于概念开发阶段,目标是实现无需燃料或外部充电的自主航行。该系统尤其适用于长时间任务、远程作业及水下平台。通信突破:12742号项目最后,12742号项目探索基于中微子的数据信号传输。与无线电信号不同,中微子可轻易穿透密集介质,几乎不受干扰。这项技术使得即便是在岩层、海洋,甚至是行星体之间,也能实现实时、加密的全球通信——为高安全级别通信及星际数据传输带来了巨大飞跃。在全球政府与产业寻找切实可行的脱碳路径之际,Neutrino® 能源集团不再只是提出解决方案,而是在切实推进落地。该集团汇聚了来自40多个国家的数百位研究人员、工程师和科学家,构建了跨学科团队,并与多方建立战略联盟,持续拓展高影响力应用领域。中微子光伏技术不再是未来的设想,它已经到来,正在征服世界。Neutrino Energy GroupNeutrino Scientific BoardHolger Thorsten Schubart - CEOWebsite: www.neutrino-energy.com联系信息Holger Thorsten SchubartCEO and member of the Scientific Advisory Boardoffice@neutrino-energy.com+493020924013相关视频https://www.youtube.com/watch?v=LiswrRR8H2Q来源: Neutrino Energy Group Copyright 2025 亚太商讯 via SeaPRwire.com.
More
英国国防部与通用原子航空系统公司签署“保护者”支持合同 ACN Newswire

英国国防部与通用原子航空系统公司签署“保护者”支持合同

圣地亚哥, 2025年6月11日 - (亚太商讯 via SeaPRwire.com) - 英国国防部已与通用原子航空系统公司(GA-ASI)签署一项关于“保护者”RG Mk1遥控驾驶飞机系统的物流与维护支持合同。该合同被称为“英国保护者可用性与支持方案”(UK PASS),将为由 GA-ASI 提供、目前由英国皇家空军(RAF)操作的新型“保护者”遥控驾驶飞机系统提供持续支持。该型号的“保护者”遥控机基于 GA-ASI 的 MQ-9B SkyGuardian®平台。照片来源:英国皇家空军UK PASS 是一项直接商业销售(Direct Commercial Sale)合同,涵盖对“保护者”项目中遥控驾驶飞机(RPA)、可认证地面控制站以及仿真训练系统的支持。“这份合同标志着英国皇家空军部署‘保护者’遥控系统的重要里程碑,”通用原子公司欧洲 MQ-9B 副总裁克里斯·杜塞尔(Chris Dusseault)表示,“随着 UK PASS 合同的签订,我们可以从测试和开发阶段正式过渡到皇家空军飞行员的操作训练阶段。”UK PASS 是通用原子公司“天空守护者全球支持方案”(SkyGuardian Global Support Solutions,简称 SGSS)的一部分,SGSS 为 MQ-9B 所有用户提供支持。该方案采用共享的承包商后勤支持(Contractor Logistics Support, CLS)模式,将维护、供应管理及其他所需的支持功能所涉及的人员、物资和间接资源统一整合,供所有客户共同使用。这种方式提升了效率,并为客户降低了成本。“PASS 合同的签订是通用原子公司与英国国防部跨领域团队三年来密切合作的成果,它将一个概念转化为现实。我们为皇家空军的‘保护者’机队打造了首个同类中的可持续支持解决方案,依托的是全球通用备件池中的承包商自有库存。该合同不同于传统的备件和维修合同,而是通过多客户通用运营模式实现规模经济,”英国皇家空军无人机系统3组组长里奇·卡梅伦上校(Group Captain Rich Cameron)表示。通用原子公司的 MQ-9B 是目前世界上最先进的遥控驾驶飞机系统,具备卓越的续航能力和作战范围。MQ-9B 包括“天空守护者”(SkyGuardian)和“海洋守护者”(SeaGuardian®)两个型号,目前已向英国皇家空军(即“保护者”项目)交付多架,并获得来自加拿大 、波兰、日本海上保安厅、日本海上自卫队、台湾、印度及美国空军(用于特种作战司令部支持)的订单。MQ-9B 也曾参与多项美国海军演习,包括“北方利剑”(Northern Edge),“一体化作战问题”(Integrated Battle Problem)和“联合航行演训”(Group Sail)。关于 GA-ASI通用原子航空系统公司(GA-ASI)是通用原子公司的子公司,致力于设计和制造成熟可靠的远程驾驶航空系统(RPA)、雷达及电光和相关任务系统,包括 Predator® RPA 系列和 Lynx® 多模式雷达。GA-ASI 运营超过 800 万飞行小时,提供具备长航时和任务能力的航空平台,并集成传感器和数据链系统,以实现持续态势感知。公司还研发多种传感器控制和图像分析软件,提供飞行员培训及支持服务,并开发超材料天线。更多信息,请访问: www.ga-asi.com 。Avenger、Gray Eagle、Lynx、Predator、Reaper、SeaGuardian 和 SkyGuardian 均为通用原子航空系统公司在美国及其他国家/地区注册的商标。联系信息GA-ASI Media Relationsasi-mediarelations@ga-asi.com(858) 524-8101来源: General Atomics Aeronautical Systems, Inc. Copyright 2025 亚太商讯 via SeaPRwire.com.
More
Blockpass partners with CryptoSwift to deliver global Travel Rule Compliance ACN Newswire

Blockpass partners with CryptoSwift to deliver global Travel Rule Compliance

HONG KONG, June 11, 2025 - (ACN Newswire via SeaPRwire.com) - Identity verification and regulatory compliance provider Blockpass is excited to announce a new partnership as it begins working with CryptoSwift OÜ, the Travel Rule compliance service, to enhance and simplify the process of meeting regulatory standards around the world. This endeavor will see CryptoSwift’s Travel Rule compliance measures added to Blockpass’ suite of regulatory solutions, enabling one-stop access to comprehensive compliance.Blockpass, the Safe Network for Crypto™, has pioneered reusable identities and crypto-native KYC/AML solutions. Its turnkey suite of compliance tools is designed to lower onboarding costs, automate remediation, prove humanity and protect against malicious actors, fraudulent activities, bots, and AI. Businesses can set up services quickly, test them for free, and start verifying users. With around one million verified identity profiles, Blockpass facilitates instant onboarding, and to date over a thousand businesses have taken advantage of this opportunity to benefit from Blockpass’ compliant network.Estonian-based CryptoSwift has been working to further crypto compliance since 2022, enabling companies to meet Travel Rule requirements whilst continuing to innovate. The solution focuses on simplicity, security, and efficiency with an easy-to-integrate API. CryptoSwift facilitates the secure transmission of required data between Virtual Asset Service Providers (VASPs) by automating compliance, providing real-time transaction monitoring whilst meeting both FATF guidelines and MiCA regulations, ensuring compliant transfers of digital assets."The Travel Rule is rapidly becoming an essential part of the compliance landscape as more and more countries around the world implement the FATF’s recommendations to secure the crypto space.” said Blockpass CEO Adam Vaziri. “We’re delighted to be working with CryptoSwift towards our mutual goals of facilitating compliance for those innovating or working in crypto.”“Partnering with Blockpass is a natural step forward in our mission to make regulatory compliance seamless for the crypto industry," said Indrek Ulst, Founder and CEO of CryptoSwift. “Blockpass shares our vision of reducing friction without compromising security or compliance. By combining our Travel Rule infrastructure with their leading KYC and AML solutions, we’re enabling crypto businesses to meet global regulatory standards with greater speed, confidence, and simplicity.”With this new partnership, Blockpass brings CryptoSwift’s services to its entire userbase and enables those seeking to comply with the vital Travel Rule recommendations. Through bringing all a company’s compliance needs to one place, Blockpass and CryptoSwift continue to work tirelessly to take the burden of regulatory compliance off the innovators in the crypto space whilst keeping them safe and secured against threats.To further support the Web3 industry, Blockpass has developed the Crypto Travel Rule Hub providing a comprehensive knowledge base, detailed country-specific regulatory insights, and a VASP-to-VASP network to help businesses navigate global compliance.About BlockpassEmbrace seamless compliance with Blockpass, the ultimate turnkey solution for KYC, KYB, and AML. Built by compliance veterans and crypto-natives, our cost-effective suite lets you automate processes, eradicate fraud, and onboard globally with confidence. Instantly activate compliant KYC/AML for DeFi, exchanges, token launchpads, and more. Leverage the Advanced KYC Bot™ for intelligent remediation, On-Chain KYC® for data-free anonymity, and Unhosted Wallet KYC™ to meet Crypto Travel Rule regulations. Navigate evolving standards with our dedicated Travel Rule Hub, a resource for global crypto compliance. Expand your reach effortlessly through our network of one million pre-verified users and three thousand businesses. Join industry leaders like Animoca Brands, Cardano, Polygon, and most crypto launchpads who all partner with Blockpass for trusted compliance and accelerated growth. Join the cutting edge of secure, streamlined onboardings.Learn more and engage the Blockpass team:Website: http://www.blockpass.orgTravel Rule Hub: https://www.blockpass.org/crypto-travel-hub/Email: sales@blockpass.orgAbout CryptoSwiftCryptoSwift is a compliance technology company delivering Travel Rule solutions for the crypto industry. Founded in 2022, CryptoSwift helps virtual asset service providers (VASPs), crypto asset service providers (CASPs), exchanges, and financial institutions meet evolving regulatory requirements such as FATF, MiCA, and TFR standards through a powerful, API-first platform designed for simplicity, security, and scalability. Backed by open-source protocols and led by fintech experts, CryptoSwift ensures compliant crypto transfers without borders or hassle.Whether you’re running an exchange or bridging crypto transfers across various blockchain technologies, CryptoSwift supports your growth with compliance you can trust.Join the CryptoSwift network to enable scalable crypto transactions and stay compliant.Learn more and connect with the CrypoSwift team:Website: https://cryptoswift.eu/Email: sales@cryptoswift.eu Copyright 2025 ACN Newswire via SeaPRwire.com.
More

爆款IPO前瞻:“香水第一股”颖通控股强势登场!港股IPO再现黄金赛道 龙头势掀“嗅觉经济”新浪潮

香港,2025年6月10日 - (亚太商讯 via SeaPRwire.com) - 随着港股IPO市场热度回升,中国除品牌所有者之外最大的香水集团颖通控股已正式通过港交所聆讯,剑指"香水第一股"之位。作为除品牌拥有者以外,中国(包括香港及澳门)规模最大的香水集团,颖通控股拥有包括Hermès Beauty、Van Cleef & Arpels、Versace、COACH、Laura Mercier、Albion和Elegance 等72个国际知名品牌的授权,具备强大的品牌组合优势。公司近年营收稳步增长,年度收入突破人民币20亿元,盈利能力亦持续提升,基本面表现稳健。其核心业务聚焦于中国高端香水市场,该赛道复合年增长率达15%,在消费升级与审美趋势驱动下,市场潜力可观。凭借稀缺的业务定位与行业领先地位,颖通控股有望成为继美妆新股"冻资王"毛戈平之后,引发市场高度关注的IPO焦点新股,并为投资者带来新一轮的增长机遇。招股书披露,颖通核心业务涵盖第三方品牌授权产品的销售与分销,以及为品牌授权方提供全方位市场拓展服务,包括品牌管理、定制化市场进入及扩张策略的设计与实施。截至2025年3月31日,颖通为合共72个外部品牌组合进行产品分销及市场部署,其中61个品牌享有独家授权或分授权。业务版图覆盖香水、彩妆、护肤品、个人护理产品、眼镜及家居香氛等多元品类,形成显著的规模优势。值得注意的是,作为国际奢侈品牌进入中国市场的合作伙伴,颖通通过独家授权体系获得品牌方深度信任,进行线上线下全域营销,这一差异化优势持续强化颖通行业领导地位。颖通拥有广阔的销售及分销网络,线下业务覆盖了400多个城市,有超过100个直接经营的线下POS及超过8,000个由零售商客户经营的POS出售;线上电商管道亦不断发力,积极布局社交媒体和电商渠道,同时驱动免税业务,形成全方位布局。财务方面,颖通的经营业绩稳健增长,彰显其经营韧性。截至2025年3月31日止年度,收入分别为人民币16.99亿元、18.64亿元、20.83亿元;同期,录得纯利为人民币1.73亿元、2.06亿元、2.27亿元;毛利率亦保持稳定于50%以上。颖通挟"嗅觉经济"东风强势登场,配合中产消费升级与Z世代对个性化香氛的刚需,这只"香水第一股"凭扎实品牌矩阵与全渠道运营实力,极可能复制美妆板块上市热潮,长线看更吃尽"嗅觉经济"的结构性红利,结合行业增长潜力与公司基本面,实力新股值得市场持续关注。 Copyright 2025 亚太商讯 via SeaPRwire.com.
More

联想控股副总裁于浩:在技术变革中锚定”长期主义”

香港,2025年6月10日 - (亚太商讯 via SeaPRwire.com) - 新华财经香港6月9日电(记者李柏涛)近年来,全球产业链与科技竞争格局加速重构,人工智能、半导体、新能源等领域的博弈愈演愈烈,企业如何应对和突围?近日,联想控股副总裁、前瞻技术研究院院长于浩在接受记者专访时表示,作为深度参与国际分工的科创企业,联想控股的答案藏在"长期主义"里。"坚持自主创新不是选择题,而是生存题。"于浩直言,从40年前中国科学院创业企业到如今横跨多领域的科技巨头,联想控股坚持长期主义走的每一步都紧扣国家战略,同时也契合自身发展和市场需求。事实证明联想控股走长期主义路线是对的。根据最新财报,2024年联想控股通过各项有效举措,打了一场业绩翻身仗:总营收为人民币5128.06亿元,同比增长17.61%;净利润为76.83亿元,同比大增1119.52%;归母净利润为1.33亿元,较2023年的-38.74亿元实现扭亏为盈。正如联想控股董事长宁旻表态,回首四十年发展之路,中国的发展给了联想控股巨大发展空间,怀着产业报国的初心和使命,我们将紧抓科技浪潮机遇,系统性提升科技创新能力,继续走好创新驱动发展之路。面对国际环境剧变,于浩在采访中透露了联想控股的科技创新发展关键词:长期研发投入、技术自主化攻坚、新兴产业赋能、构建前瞻科技共创孵化体系。立足中长期 坚持自主化创新经过多年发展,联想控股摸索出具有自身特色的科技产业化道路,这也助其发展成为世界领先的科技企业。同时,联想控股体系持续重视科技创新与研发投入,2024年研发投入158亿元,创历史新高。于浩表示,自1984年创业起,联想通过积累资金和办企经验,之后慢慢实现规模化生产,逐步建立自己的品牌、全球研发体系,最终实现了联想特色的科技产业化。最新数据显示,联想控股旗下的联想集团在今年一季度全球PC出货量市场份额占比为25.9%,继续稳坐全球第一。同时,随着多元化战略深入推进,联想集团业务结构也得到持续优化,截至二零二四/二五财年,非PC业务营收占比升至47%。对于科技行业里的"卡脖子"难题,联想控股旗下联泓新科重点关注相关领域,正在努力推动高端新材料的国产替代;旗下的富瀚微深耕以视频为中心的芯片设计开发,致力成为业界领先的芯片产品和技术服务提供商。其中,2010年成立的联泓新科是从零开始构建的绿地项目,经过多年发展,已成为国家高新技术企业、全球新能源企业500强,重点关注国家需要和市场紧缺的高端新材料"卡脖子"领域,涵盖光伏、新能源电池、生物可降解、电子特种气体等多种领域的新材料。"我们选择合作项目时会看早、看小,特别是在有更多破坏性创新机会的'达尔文海'领域,也就是不去跟一些创投基金去拼抢现有项目,而选择一些大家可能没注意到或者暂时无法顾及的项目,并做中长期布局。"于浩说。聚焦新材料、新能源、智能传感三大领域为推动科技创新领域的可持续发展,联想控股专门成立了前瞻技术研究院,对趋势性未来技术提前布局,筛选前沿科技种子技术,与高潜力创新团队共同设计产业化路线并完成科研成果转化与产业落地。"前瞻技术研究院是推动科技创新战略向纵深发展的前哨,有别于科研院校和创投机构,其纵贯从实验室到产业化的整个创新发展生命周期。"于浩介绍,大方向上重点关注新材料、新能源、智能传感三大领域的前瞻性技术,通过调研分析市场需求,评估备选种子技术潜力,结合产业链上下游和业界反馈,研判未来产业化空间。于浩表示,研究院团队融合了"技术应用产品经理"和"产投融资财务顾问"双重身份,以打通"从书架到货架""从论文到产品""从专利到变现"的端到端转化路径为目标。目前,团队已与包括北大、清华等多所高校以及中国科学院体系科研院所建立共创合作网络,围绕服务于未来新兴产业的技术突破开展前瞻布局。在访谈中发现,把海外领先成熟技术导入国内,助力本土企业解决痛点难点,同时借助国内巨大市场规模效应放大技术商业价值,也是该研究院的重要布局。于浩介绍,利用积累的日系渠道资源,研究院建立了中日双循环开放创新镜像体系,正在借助实际项目验证优化这个体系。其中一个典型案例是从日本引进的精细发泡技术,致力于缓解白色污染。"通过引进国际领先的新材料加工技术,在降低单位成本的基础上,结合国内市场新应用,创新性地将核心技术转化为新质生产力,通过技术导入实现四两拨千斤。"于浩说。聚点成面、汇面成体,抢占AI时代先机谈及AI,于浩表示,人工智能已成为全球科技竞争的核心赛道。他对未来AI产业发展的愿景是:差异化应用百花齐放,应用侧反哺AI产业链,软硬协同优化,技术、市场螺旋式上升,从局部数智化改造向全局"新质生产力"体系跃迁。事实上,围绕"人工智能+"战略,联想控股体系在教育、医疗、交通、制造、ESG等多个垂直领域形成协同效应。智谱AI与清华大学合作的AI助教系统在多门课程中实现试点应用、被投企业深睿医疗获批国内首个肺癌AI诊断认证、智谱AI与高通合作为汽车厂商提供端侧专属智能体解决方案、联想集团与弘信电子集团联合研发智能生产系统、联想集团与生态环境部共建应对全球气候变化和生物多样性保护等全球性议题的AI技术应用平台..."面对AI浪潮,联想控股选择'全产业链卡位',布局了超270家AI产业链企业,形成从算法到落地的生态闭环。"于浩表示,包括地平线机器人、黑芝麻智能、小马智行已在2024年成功登陆资本市场,所投企业中有180家获评为国家级专精特新"小巨人"企业。于浩认为,这种"聚点成面、汇面成体"的策略,可以帮助公司在生成式AI时代占据先机。他说,本轮以大语言模型技术路线主导的AI,已成功跨越"图灵测试",接下来面对的挑战是突破"缸中之脑",发展具身智能是通往AGI(通用人工智能)的必经之路。截至2024年底,联想控股体系在具身智能领域投资企业近40家,涵盖上游材料、核心零部件、智算芯片、模型算法、机器人、下游应用及解决方案等全产业链布局。于浩表示,借助联想控股的体系资源,期待孵育出越来越多优秀AI公司,不仅服务于国内市场,更要积极"出海",提升全球影响力。 Copyright 2025 亚太商讯 via SeaPRwire.com.
More
U.S. Polo Assn. Returns as Official Apparel and Jersey Partner for Chestertons Polo in the Park in Downtown London ACN Newswire

U.S. Polo Assn. Returns as Official Apparel and Jersey Partner for Chestertons Polo in the Park in Downtown London

West Palm Beach, FL, June 10, 2025 - (ACN Newswire via SeaPRwire.com) - U.S. Polo Assn., the official brand of the United States Polo Association (USPA), proudly served once again as the Official Apparel and Jersey Partner for Chestertons Polo in the Park, one of the world's largest and most iconic polo lifestyle festivals. Held June 6-8, 2025, at the historic Hurlingham Park in the heart of London, this year's edition welcomed over 30,000 attendees across three thrilling days of international polo, sport-inspired fashion, and family-friendly entertainment.U.S. Polo Assn. at Chestertons Polo in the ParkTeam Riyadh and Tournament MVP Cesar Crespo and Arkham Team Punta Cana’s Tommy Severn Battling for the Ball at Chestertons Polo in the Park Wearing the Iconic Double Horsement Logo From Apparel and Jersey Sponsor U.S. Polo Assn.As the Official Apparel and Jersey Partner, U.S. Polo Assn. outfitted all participating teams of the weekend, as well as staff uniforms. The brand also hosted an immersive on-site experience for event attendees, featuring a vibrant U.S. Polo Assn. merchandise tent showcasing official co-branded event apparel, a polo-inspired photo wall, and interactive brand models, along with contests and cap giveaways.Now in its 15th year, Chestertons Polo in the Park is the only polo event played in central London and continues to grow in prestige and popularity as Europe's largest three-day polo and lifestyle event with action-packed polo games, food festivals, luxury shopping, entertainment, and more. The highly anticipated weekend kicked off with International Day on Friday, as England faced Argentina, alongside six world-class polo teams representing different global cities, followed by Saturday's Ladies Day, and the culminating event on Sunday with Finals and Family Day, drawing crowds of polo enthusiasts from the U.K. and across the globe. Team Riyadh won the weekend's tournament against Akrham Team Punta Cana with a score of 10-5, and Cesar Crespo from Team Riyadh was awarded Tournament MVP."Chestertons Polo in the Park is a one-of-a-kind event that brings together the spirit of polo, our U.S. Polo Assn. brand, and the energy of London in a fun, stylish, and accessible way," said J. Michael Prince, President and CEO of USPA Global, the company that manages and markets the U.S. Polo Assn. brand. "Our sponsorship reinforces the authentic connection between our brand and the sport of polo while helping us further engage U.K. consumers in one of our most important and fastest-growing markets."The global, multi-billion-dollar U.S. Polo Assn. brand continues to expand across the United Kingdom with store openings at McArthurGlen's East Midlands and Cheshire Oaks and additional brick-and-mortar locations planned in the coming years. U.K. consumers can also explore the brand's latest sport-inspired styles for men, women, and children at www.uspoloassn.co.uk."As the strategic partner of U.S. Polo Assn. in the U.K., Chestertons Polo in the Park is an ideal platform to showcase our sport-inspired brand's connection to historic English polo," said Boo Jalil, CEO of Brand Machine Group, U.S. Polo Assn.'s U.K. licensing partner. "This annual celebration not only builds brand visibility in a meaningful way, but also highlights the fun, fashion-forward, and approachable spirit of U.S. Polo Assn."Set against the backdrop of one of polo's most historic venues - Hurlingham Park, where the sport was first played in 1874, the event reflects decades of tradition, including hosting the 1908 Olympic Polo Final and multiple Westchester Cup matches between the United States and England."U.S. Polo Assn. is the perfect fit for Chestertons Polo in the Park, and we value the continued support," said Rory Heron, Managing Director of Sportgate International, the founding organizer of the event. "The brand's meaningful connection to the game and globally recognized style brings authenticity, accessibility, and innovative activations to our spectacular annual celebration of sport and lifestyle in London."Photo Captions:1. Team Riyadh and Tournament MVP Cesar Crespo and Arkham Team Punta Cana's Tommy Severn Battling for the Ball at Chestertons Polo in the Park Wearing the Iconic Double Horsement Logo From Apparel and Jersey Sponsor U.S. Polo Assn.2. U.S. Polo Assn. Merchandise Pop-Up at Chestertons Polo in the Park3. Event Attendees Posing With Models of Official Apparel Sponsor U.S. Polo Assn.4. Chestertons Polo in the Park Player Noor Khadra Signing U.S. Polo Assn. Caps, Given Out at the Spectacular Three-Day Lifestyle Event5. Beautiful Chestertons Polo in the Park Guests Posing in U.S. Polo Assn. Caps, Given Out at the Spectacular Three-Day Lifestyle EventPhoto Credit: Jen DeberignyAbout U.S. Polo Assn.U.S. Polo Assn. is the official brand of the United States Polo Association (USPA), the largest association of polo clubs and polo players in the United States, founded in 1890 and based at the USPA National Polo Center in Wellington, Florida. This year, U.S. Polo Assn. celebrates 135 years of sports inspiration alongside the USPA. With a multi-billion-dollar global footprint and worldwide distribution through more than 1,100 U.S. Polo Assn. retail stores as well as thousands of additional points of distribution, U.S. Polo Assn. offers apparel, accessories, and footwear for men, women, and children in more than 190 countries worldwide. Historic deals with ESPN in the United States and Star Sports in India now broadcast several of the premier polo championships in the world, sponsored by U.S. Polo Assn., making the thrilling sport accessible to millions of sports fans globally for the very first time.U.S. Polo Assn. has consistently been named one of the top global sports licensors in the world alongside the NFL, NBA, and MLB, according to License Global. In addition, the sport-inspired brand is being recognized internationally with awards for global and digital growth. Due to its tremendous success as a global brand, U.S. Polo Assn. has been featured in Forbes, Fortune, Modern Retail, and GQ, as well as on Yahoo Finance and Bloomberg, among many other noteworthy media sources around the world.For more information, visit uspoloassnglobal.com and follow @uspoloassn.About Brand Machine Group (BMG)BMG is an international leader in fashion innovation which has established itself as a vertical manufacturer and global licensing specialist with over four decades of industry experience. Partnering with recognized market leaders, BMG manages a seamless and collaborative process of designing, manufacturing, and delivering quality products while championing the DNA of a diverse portfolio of brands, spanning fashion, sports, outdoor, and homeware including adult fashion, kidswear, and accessories.BMG's portfolio of brands includes U.S. Polo Assn. Penfield, New Balance Kids, Duchamp, Jack Wills, Flyers American Born, Lee Kids, Peckham Rye, Wrangler Kids, Juicy Couture, Franklin & Marshall, Elle Junior and Ben Sherman. BMG reaffirms its commitment to upholding sustainable and ethical business practices by ensuring full transparency throughout its global supply chain, aligning with the ETI Base Code.Visit brandmachinegroup.com and follow @brandmachinegroup. For appointments, contact sales@brandmachinegroup.com.About Sportgate InternationalSportgate International is an international event management and sports marketing agency. Established in 2015, Sportgate International now owns events and consults with companies, luxury brands, world-class venues, tourism boards, and rights holders requiring sponsorship and event expertise. Sportgate International owns a portfolio of luxury events which encourages and enables the world's best brands, top companies, and individuals to further their corporate or personal objectives. The company also works with some of the most high-profile venues in the world, offering original content that enables networking and marketing to specific audiences.For more information, visit sportgateint.com.Contact InformationShannon StilsonVP, Sports Marketing and Mediasstilson@uspagl.com+001.561.227.6994Stacey KovalskyVP, Global PR and Communicationsskovalsky@uspagl.com+001.561.790.8036SOURCE: U.S. Polo Assn.Related ImagesU.S. Polo Assn. at Chestertons Polo in the ParkU.S. Polo Assn. Merchandise Pop-Up at Chestertons Polo in the ParkU.S. Polo Assn. at Chestertons Polo in the ParkEvent Attendees Posing With Models of Official Apparel Sponsor U.S. Polo Assn.U.S. Polo Assn. at Chestertons Polo in the ParkChestertons Polo in the Park Player Noor Khadra Signing U.S. Polo Assn. Caps, Given Out at the Spectacular Three-Day Lifestyle EventU.S. Polo Assn. at Chestertons Polo in the ParkBeautiful Chestertons Polo in the Park Guests Posing in U.S. Polo Assn. Caps, Given Out at the Spectacular Three-Day Lifestyle Event Copyright 2025 ACN Newswire via SeaPRwire.com.
More
New HKTDC Chairman Frederick Ma keen to promote Hong Kong as best partner for global enterprises ACN Newswire

New HKTDC Chairman Frederick Ma keen to promote Hong Kong as best partner for global enterprises

HONG KONG, Jun 9, 2025 - (ACN Newswire via SeaPRwire.com) - The Hong Kong Trade Development Council (HKTDC)’s new Chairman Prof Frederick Ma met with media today, outlining the HKTDC’s strategic direction to help Hong Kong enterprises navigate global challenges and seize new opportunities.Prof Ma said: “The international trade landscape is turbulent, and enterprises urgently need to reassess their development strategies. As both a springboard for the country and an international hub, Hong Kong possesses the unique advantages of internal and external connectivity and is poised to play a pivotal role in the new trade landscape.”He pointed out that HKTDC will help Hong Kong businesses connect globally and turn challenges into opportunities. Through three strategic directions —1) reinforcing Hong Kong’s role as a superconnector and super value-adder to highlight its international status and deepen ties with global markets, 2) building a multinational supply chain management centre, and 3) promote trade digitalisation to position Hong Kong as the best partner for global enterprises, helping SMEs to stand out in an ever-changing world.The HKTDC will leverage its network of 51 offices globally and 49 Hong Kong business associations to support enterprises in exploring new markets and enhancing competitiveness. Prof Ma said: “Hong Kong has always been a city of opportunities. The HKTDC will stand side by side with Hong Kong businesses, seizing opportunities in an ever-changing world, integrating Hong Kong into national development and telling the good stories of Hong Kong and Mainland China.”Five directions to forge a new chapter for Hong Kong1.Advancing our strengths in internal and external connectivity and leveraging our global network, enhancing overseas visits and flagship promotions: Reviewing the HKTDC’s global network of 51 offices to reinforce our work in key markets and enhance Hong Kong’s international competitiveness. The HKTDC will continue organising more trade missions to tell the good stories of Hong Kong and Mainland China. A prime example is our flagship campaign Think Business, Think Hong Kong, which will be held in Milan, Italy in November.2.Optimising existing flagship events: By incorporating industry collaboration elements into the annual Asian Financial Forum (AFF), we will transform it into AFF Plus to facilitate connections between finance and the real economy, driving innovation, regional integration and sustainable development. For trade fairs, we will strengthen content related to global trends, including elements of robotics and higher education. Additionally, we will host new events targeting key markets, like the Middle East, inviting mainland enterprises to participate, to promote trade and investment cooperation between Hong Kong and countries in the Middle East region.3.Building an international supply chain management centre: In response to the trend of mainland industrial chains extending overseas, the HKTDC will actively position Hong Kong as a supply chain command centre to support mainland firms in going global.4.Driving the innovation engine and promoting trade digitalisation: The HKTDC will enhance existing support services, focusing on core elements of trade digitalisation to help SMEs leverage technologies - such as IOT, AI, blockchain and big data – to boost efficiency. In the long term, the HKTDC aims to position Hong Kong as a value chain centre, utilising technology, data analytics and collaborative networks to refine value chains for global enterprises, creating added value and addressing market changes and uncertainties.5.Explore long term demand for the convention and exhibition industry: The HKTDC will support the Hong Kong SAR Government in reviewing the needs of the convention and exhibition sector in the long term.Photo download: https://bit.ly/440xPHs HKTDC Chairman Prof Frederick Ma and Executive Director Margaret Fong met with media today to introduce the latest strategies for HKTDC to support SMEs and help them tackle business challengesHKTDC Chairman, Professor Frederick MaThink Business, Think Hong Kong Paris organised by the HKTDC was successfully held in Paris, France in 2023, attracting more than 1,300 participants. The event will be held in Milan, Italy this NovemberThe annual Asian innovation and technology event, InnoEX presents a range of low-altitude economy solutions, such as drones and aerial vehicles, to drive innovative developmentThe HKTDC hosts numerous major exhibitions and conferences in Hong Kong annually to foster trade collaboration. Pictured is this year’s Hong Kong International Jewellery Show held at the Hong Kong Convention and Exhibition CentreThe HKTDC has organised a delegation of Hong Kong enterprises to participate in the China International Import Expo for seven consecutive years. Last November, it led 52 Hong Kong companies to exhibit at the Hong Kong Product Pavilion and Hong Kong Service Pavilion. Moving forward, the HKTDC will continue to promote Hong Kong’s high-quality products and professional services to the mainland and international business communities.Media enquiriesPlease contact the HKTDC’s Communications & Public Affairs Department:Serena CheungTel: (852) 2584 4272Email: serena.hm.cheung@hktdc.orgSunny NgTel: (852) 2584 4357Email: sunny.sl.ng@hktdc.orgAgnes WatTel: (852) 2584 4554Email: agnes.ky.wat@hktdc.orgAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Copyright 2025 ACN Newswire via SeaPRwire.com.
More
UK MOD Signs Protector Support Contract with GA-ASI ACN Newswire

UK MOD Signs Protector Support Contract with GA-ASI

SAN DIEGO, CA, June 10, 2025 - (ACN Newswire via SeaPRwire.com) - The United Kingdom's Ministry of Defence has signed a support and sustainment contract with General Atomics Aeronautical Systems, Inc. (GA-ASI) for logistics and maintenance of the Protector RG Mk1 Remotely Piloted Aircraft (RPA) system. The contract - known as the UK Protector Availability and Support Solution or UK PASS - will provide ongoing support for the new Protector RPA systems supplied by GA-ASI and now being operated by the UK's Royal Air Force (RAF). The Protector RPA is based on GA-ASI's MQ-9B SkyGuardian®.Photo: Royal Air ForceUK PASS is a Direct Commercial Sale contract and includes support for the Protector program's RPA, the Certifiable Ground Control Stations and the Synthetic Training Systems."This contract marks an essential milestone in the fielding of the Protector RPA system for the RAF," said Chris Dusseault, Vice President of MQ-9B in Europe. "With the UK PASS contract in place, we can now transition from the test and development phase of the program to training the RAF flight crews for operations."UK PASS is part of GA-ASI's SkyGuardian Global Support Solutions (SGSS), which provides support for the entire MQ-9B customer base. SGSS is a shared Contractor Logistics Support (CLS) model, with resources such as labor, material, and overhead for maintenance, supply management, and other support functions required to sustain the RPA system, pooled together for use by the entire customer base. This approach provides efficiencies and a lower cost for customers."The awarding of the PASS contract marks three years of intensive work between GA-ASI and UK MOD multidisciplinary teams to turn a concept in to a reality. This has generated a first-in class sustainment solution for the Royal Air Force Protector fleet, that exploits contractor owned inventory from a global common spares pool. This contract differs from a traditional spares and repairs contract, achieving economies of scale via a multi-customer common operating model," said Group Captain Rich Cameron - Uncrewed Air System 3 Team Leader.GA-ASI's MQ-9B is the world's most advanced RPA system, delivering exceptionally long endurance and range. MQ-9B includes the SkyGuardian and SeaGuardian® models, with multiple deliveries made to the U.K.'s Royal Air Force (Protector), as well as orders from Canada, Poland, the Japan Coast Guard, the Japan Maritime Self-Defense Force, Taiwan, India, and the U.S. Air Force in support of the Special Operations Command. MQ-9B has also supported various U.S. Navy exercises, including Northern Edge, Integrated Battle Problem, and Group Sail.About GA-ASIGeneral Atomics Aeronautical Systems, Inc., is the world's foremost builder of Unmanned Aircraft Systems (UAS). Logging more than 8 million flight hours, the Predator® line of UAS has flown for over 30 years and includes MQ-9A Reaper®, MQ-1C Gray Eagle® 25M, MQ-20 Avenger®, and MQ-9B SkyGuardian®/SeaGuardian®. The company is dedicated to providing long-endurance, multi-mission solutions that deliver persistent situational awareness and rapid strike.For more information, visit www.ga-asi.com.Avenger, EagleEye, Gray Eagle, Lynx, Predator, Reaper, SeaGuardian, and SkyGuardian are trademarks of General Atomics Aeronautical Systems, Inc., registered in the United States and/or other countries.Contact Information:GA-ASI Media Relationsasi-mediarelations@ga-asi.com(858) 524-8101SOURCE: General Atomics Aeronautical Systems, Inc. Copyright 2025 ACN Newswire via SeaPRwire.com.
More

Everest Medicines Presents Positive Results from Phase 1b/2a Clinical Trial of EVER001 for Primary Membranous Nephropathy at ERA 2025

HONG KONG, Jun 9, 2025 - (ACN Newswire via SeaPRwire.com) - At the 62nd European Renal Association Congress (ERA 2025), Everest Medicines unveiled new clinical data on EVER001 (previously known as XNW1011), a next-generation covalent reversible Bruton's tyrosine kinase (BTK) inhibitor, in patients with primary membranous nephropathy (pMN). This marks the first time EVER001’s clinical data have been unveiled at an international academic congress. This initial unveiling of the preliminary data at an international congress focuses on pMN. The results showed encouraging signals in terms of novel mechanism, preliminary efficacy, and safety. These findings provide a solid foundation for future therapeutic strategies in proteinuric autoimmune glomerular diseases including pMN and demonstrate Everest’s advancing innovation capabilities and global development momentum.EVER001 is a covalent reversible BTK inhibitor with potentially best-in-class characteristics for the treatment of primary membranous nephropathy (pMN) and other autoimmune renal diseases, including IgA nephropathy (IgAN), minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), and lupus nephritis (LN). These conditions affect over 10 million patients worldwide. There are approximately 2 million pMN patients in China alone and nearly 220,000 across the United States, Europe, and Japan. There are currently no approved therapies globally, and existing treatments rely heavily on non-specific immunosuppressants, which have limited efficacy and safety concerns, highlighting the urgent need for novel mechanism-based therapies.Everest Medicines holds global rights to EVER001 for the treatment of renal diseases. As a covalent reversible BTK inhibitor, EVER001 combines high target-binding affinity with enhanced selectivity, helping to reduce off-target toxicity seen in earlier-generation BTK inhibitors. Its favorable safety and efficacy profile supports its potential to become a new standard of care across proteinuric glomerular diseases.At ERA 2025, preliminary data from the ongoing Phase 1b/2a trial showed that EVER001 was well tolerated and demonstrated promising efficacy in patients with primary membranous nephropathy (pMN). The study enrolled 31 biopsy-confirmed pMN patients who were positive for anti-PLA2R autoantibodies and received either low or high doses of EVER001 over a 36-week treatment period, with extended follow-up for someparticipants. By week 12, anti-PLA2R autoantibody levels dropped by 62.1% in the low-dose group and 87.3% in the high-dose group. Both cohorts saw reductions of approximately 93% by week 24, with 76.9% and 81.8% of patients, respectively, achieving immunologic complete remission. For 24-hour proteinuria, the low-dose group achieved a 78.0% reduction at week 36, sustained through week 52, with 69.2% reaching clinical remission. In the high-dose group, proteinuria declined by 70.1% at week 24, with 80.0% of patients achieving clinical remission.EVER001 was generally well tolerated. No clinically significant adverse events commonly associated with covalent irreversible BTK inhibitors—such as bleeding, arrhythmia, severe infections, or liver dysfunction—were observed. Most treatment-related adverse events were mild to moderate (Grade 1–2), further supporting its long-term therapeutic potential.EVER001 is expected to generate strong portfolio synergies with Everest’s commercial-stage product, NEFECON®, the first and only fully approved etiological treatment for IgAN in China, the U.S., and Europe. NEFECON® was added to China’s National Reimbursement Drug List (NRDL) in November 2024, and has been included in the KDIGO 2024 Clinical Practice Guideline For The Management Of Immunoglobulin A Nephropathy (IgAN) And Immunoglobulin A Vasculitis (IgAV) (public review draft), making it the only targeted therapy endorsed by both international and Chinese guidelines, establishing its position as a first-line therapy. To further enhance its IgAN strategy, Everest is also developing a diagnostic test for Gd-IgA1, enabling earlier detection, more accurate disease stratification, and treatment monitoring.By integrating diagnostics and therapeutics into a unified care model, Everest is leading the transition from supportive care to precision, disease-modifying treatment for immune-mediated kidney diseases such as IgAN. This holistic strategy aims to improve disease detection and management standards and establish a comprehensive, long-term renal care platform.With EVER001 and NEFECON® advancing in parallel, Everest is driving innovation in nephrology with the goal of setting new global treatment standards. The presentation of EVER001 at ERA 2025 marks a pivotal milestone in its clinical development and demonstrates the international visibility of China-originated innovations. Everest continues to pave the way for globally competitive novel therapies to reach patients around the world. Copyright 2025 ACN Newswire via SeaPRwire.com.
More